70 employees
Centre for Commercialization of Cancer Immunotherapy is to Accelerate the discovery, commercialization, and access to Cancer Immunotherapy.
2016
Inspire Biotherapeutics Inc raised undisclosed on March 15, 2023
Investors: Octane, Ontario Institute for Regenerative Medicine and C3i